Two-year Clinical Outcomes Following Everolimus-eluting Stent Use for Off-label Versus On-label Indications: From the Korean Multicenter Drug-eluting Stent Registry.
Jong Yop Pae, Kwon Bae Kim, Dae-Kyeong Kim, Ji Yong Choi, Cheol Hyun Lee(Ulsan College), Hun Sik Park(Kyungpook National University Hospital), Sang Kon Lee(Hallym University), Young Jo Kim(Yeungnam University), Dae Woo Hyun, Yong Suk Jeong
Unknown
December 1, 2018
Cited by 0
Related Papers
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
|Journal of the American College of Cardiology|2010|278